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P U B L I S H E D B Y E L S E V I E R I N C .CORRECTION
Saxena A, Izmirly PM, Han SW, Briassouli P, Rivera TL, Zhong H, Friedman DM, Clancy RM, Buyon JPSerum Biomarkers of Inﬂammation, Fibrosis, and Cardiac Function
in Facilitating Diagnosis, Prognosis, and Treatment of
Anti-SSA/Ro-Associated Cardiac Neonatal Lupus
J Am Coll Cardiol 2015;66:930–9.
There were two errors that appeared in Figure 1.
For Figure 1C, in the x axis, “Log Cord MMP2” should have been “Cord MMP2”.
For Figure 1F, “p ¼ 0.007” should have been “p ¼ 0.07”.
The correct version of the ﬁgure is printed below.FIGURE 1 Association of Cord Blood Biomarkers With Cardiac-NL Morbidity
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p = 0.02
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Regression Coefficient = 1.01
p = 0.03
Multivariate associations of serum biomarkers in anti-SSA/Ro-exposed cord blood with cardiac- NL morbidity derived from a severity score of
potential clinical outcomes. (A) Log CRP; (B) log NT-proBNP; (C) MMP2 (ng/ml); (D) uPA (ng/ml); (E) uPAR (ng/ml); (F) plasminogen (ng/ml).
Covariates were: CRP (ﬂuorinated steroid exposure, ﬂuorinated steroid exposure at time of birth, maternal IVIg); NT-proBNP (ﬂuorinated steroid
exposure at birth, maternal hydroxychloroquine, gestational age 20 weeks during winter, week of delivery); MMP2 (maternal ﬂuorinated steroid,
maternal hydroxychloroquine, gestational age 20 weeks during winter); uPA (ﬂuorinated steroid, maternal IVIg, maternal nonﬂuorinated steroid,
sex, gestational age 20 weeks during winter, week of delivery); uPAR (ﬂuorinated steroid, maternal IVIg, maternal nonﬂuorinated steroid,
maternal diagnosis of SLE or SS, sex, gestational age 20 weeks during winter, week of delivery). Plasminogen (maternal IVIg, maternal non-
ﬂuorinated steroid, sex, gestational age 20 weeks during winter). SS ¼ Sjögren’s syndrome; uPA ¼ urokinase plasminogen activator; uPAR ¼
urokinase plasminogen activator receptor.The online version has been corrected.
The authors apologize for this error.http://dx.doi.org/10.1016/j.jacc.2015.09.005
